Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Filed with HKEX · Stock code 2142 · · 10 pages · English
Summary by 6ix AI
It includes information on authorized and registered share capital, as well as movements in issued and treasury shares. The report confirms compliance with public float requirements and provides details on share options and other agreements related to share issuance. The document serves to inform the Hong Kong Exchanges and Clearing Limited about the company's securities activities during the specified month.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from HBM
- Supplemental announcement in relation to the 2025 annual report and the 2026 interim report
- Voluntary announcement - nona biosciences develops the world's first language model trained on fully human heavy-chain-only antibodies
- Harbour BioMed Announces U.S. FDA IND Clearance for HBM7004 for the Treatment of Advanced Solid Tumors
- Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Atopic Dermatitis
- Harbour BioMed Announces Positive Profit Alert for 2025 Annual Results
Later from HBM
- Next Day Disclosure Return
- Inside information announcement - nmpa approval of batoclimab injection (subcutaneous injection) for the treatment of generalized myasthenia gravis
Follow HBM into a list and get an email when it puts out news.
Follow HBM